Brian McCudden is the Global Head of Peptide Operations for Corden Pharma. Corden Pharma is a Contract Development and Manufacturing Organization (CDMO) with headquarters in Basel, Switzerland. Brian is based at their Boulder site.

Brian is responsible for Corden’s strategic peptide growth projects which includes site capital projects at the Boulder site. These expansion projects support the demand for peptides used to treat metabolic, cardiovascular, and other critical diseases.

Previously, Brian was the Site Head and Managing Director for Corden’s Boulder operations which includes two site, on 55th St. and Sterling Dr. Brian joined Corden after serving as Hospira’s Vice President of API Strategy in Lake Forest, IL. In this role Brian was responsible for developing and implementing strategy for the many Active Pharmaceutical Ingredients (APIs) that were used in the pharmaceutical medicines that Hospira developed and sold globally.

Brian is a Chemical Engineer from the University of Delaware with a MBA from Loyola University.